Tolvaptan Siadh Ratiopharm

Tolvaptan Siadh Ratiopharm is an oral medication used to treat low sodium levels caused by SIADH. It helps the kidneys retain water while increasing sodium concentration. This EU-manufactured drug is prescribed under medical supervision.

Tolvaptan is primarily used to treat hyponatremia, a condition where sodium levels in the blood are too low due to syndrome of inappropriate antidiuretic hormone secretion (SIADH). It works by helping the body remove excess water while increasing sodium concentration. This medication is typically prescribed when other treatments have not been effective.

Tolvaptan works by blocking the action of vasopressin, a hormone that regulates water retention in the body. This leads to increased urine output and a rise in sodium levels in the blood. Patients may notice more frequent urination and thirst as the body adjusts to the medication.

Tolvaptan should only be taken as directed by a healthcare professional. It is important to stay hydrated while taking this medication, but avoid excessive fluid intake unless advised otherwise. Regular blood tests are usually required to monitor sodium levels and liver function during treatment.

Tolvaptan may interact with other medications that affect liver enzymes, such as CYP3A inhibitors or inducers. Combining it with drugs that increase sodium levels or affect fluid balance should be done cautiously. Alcohol and grapefruit products may also interact with Tolvaptan.